PUTRAJAYA, 15 Sept — The registration of products assessed by the Association of Southeast Asian Nations Joint Assessment (Asean JA) process has been approved for the very first time during the 388th Drug Control Authority (DCA) of Malaysia meeting on Sept 14.

KUALA LUMPUR, Jan 7 — CanSino’s single-dose Convidecia vaccine has obtained conditional approval as a booster shot from Malaysia’s Drug Control Authority (DCA), which is under the National Pharmaceutical Regulatory Agency (NPRA).

KUALA LUMPUR, Jan 6 — The Covid-19 Comirnaty vaccine manufactured by Pfizer has been given conditional approval for the immunisation of children aged between five and 11.

KUALA LUMPUR, Dec 14 — The Health Ministry (MOH) has given conditional registration approval for use of Ronapreve Solution for Injection or Infusion in the treatment and prevention of Covid-19 in the country.

KUALA LUMPUR, Nov 17 — The 366th Drug Control Authority (DCA) meeting today agreed to give conditional approval for the use of AstraZeneca and CoronaVac vaccines as COVID-19 booster dose to individuals aged 18 and above after receiving the primary series of vaccination from the same type (homologous).

KUALA LUMPUR, July 16 — Duopharma Biotech Bhd’s (Duopharma) wholly-owned unit, Duopharma (M) Sdn Bhd (DMSB), has been granted conditional registration approval by the Drug Control Authority (DCA) for the Covid-19 Sinopharm vaccine developed by China National Biotec Group Co Ltd.

KUALA LUMPUR, June 15 — The 359th Drug Control Authority (DCA) meeting today approved the use of the Comirnaty vaccine produced by Pfizer-BioNTech for children aged 12 and above.

KUALA LUMPUR, April 23 — The 356th Drug Control Authority (DCA) meeting today agreed to approve the conditional registration for the CoronaVac Suspension for Injection Covid-19 Vaccine (Vero Cell), Inactivated’ for use during disasters.